Azithromycin
Azithromycin is a pharmaceutical drug with 313 clinical trials. Currently 29 active trials ongoing. Historical success rate of 84.7%.
Success Metrics
Based on 183 completed trials
Phase Distribution
Phase Distribution
32
Early Stage
62
Mid Stage
150
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.2%
183 of 234 finished
21.8%
51 ended early
29
trials recruiting
313
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
The Impact of Shigellosis and Recommended Treatment in Children
Improving Care Through Azithromycin Research for Infants in Africa
Azithromycin Reduction to Reach Elimination of Trachoma
A Study of Standard Drugs for Mycobacterium Avium Complex
Clinical Trials (313)
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
The Impact of Shigellosis and Recommended Treatment in Children
Improving Care Through Azithromycin Research for Infants in Africa
Azithromycin Reduction to Reach Elimination of Trachoma
A Study of Standard Drugs for Mycobacterium Avium Complex
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Antibiotic Treatment of Recurrent Episodes of Asthma in Children
Azithromycin Reduction to Reach Elimination of Trachoma B
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
Improving Cognition and Gestational Duration With Targeted Nutrition
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management
Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Eosinophil-guided Reduction of Inhaled Corticosteroids
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 313